348
Views
11
CrossRef citations to date
0
Altmetric
Gastrointestinal Cancer

Clinical course of sorafenib treatment in patients with hepatocellular carcinoma

, , , , , & show all
Pages 809-819 | Received 11 Dec 2011, Accepted 01 Apr 2012, Published online: 08 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Do Hyung Kim, Young-Il Jeong, Chung-Wook Chung, Cy Hyun Kim, Tae Won Kwak, Hye Myeong Lee & Dae Hwan Kang. (2013) Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells. International Journal of Nanomedicine 8, pages 1697-1711.
Read now

Articles from other publishers (10)

Maria Tampaki, George V. Papatheodoridis & Evangelos Cholongitas. (2023) Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview. Cancers 15:4, pages 1310.
Crossref
Young Eun Ahn, Sang Jun Suh, Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Tae Hyung Kim, Young Sun Lee, Sun Young Yim, Hae Rim Kim, Seong Hee Kang, Young Kul Jung, Ji Hoon Kim, Jong Eun Yeon, Soon Ho Um & Kwan Soo Byun. (2021) Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and Liver 15:2, pages 284-294.
Crossref
Rogério Camargo-Pinheiro-Alves, Daniele E. Viera-Alves, Arthur Malzyner, Otavio Gampel, Thaisa de F. Almeida-Costa, Betty Guz & Paula Poletti. (2019) Experience with Sorafenib in 3 Hospitals in Sao Paulo. Annals of Hepatology 18:1, pages 172-176.
Crossref
Mairéad Geraldine McNamara, Astrid E. Slagter, Christina Nuttall, Melissa Frizziero, Rille Pihlak, Angela Lamarca, Noor Tariq, Juan W. Valle, Richard A. Hubner, Jennifer J. Knox & Eitan Amir. (2018) Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma—a meta-analysis. European Journal of Cancer 105, pages 1-9.
Crossref
Ligang Chen, Yifei Zheng, Hongjian Zhang, Heng Pan, Qiusong Liu, Xu Zhou, Wei Wei, Yun Liu, Maochuan Zhen, Jinling Wang, Jianyin Zhou & Yilin Zhao. (2018) Comparative analysis of tumor‑associated vascular changes following TACE alone or in combination with sorafenib treatment in HCC: A retrospective study. Oncology Letters.
Crossref
Leonidas Apostolidis, Jan Pfeiffenberger, Daniel Gotthardt, Boris Radeleff, Arianeb Mehrabi, Peter Schemmer, Dirk Jäger, Peter Schirmacher, Wolfgang Stremmel, Henning Schulze-Bergkamen, Christoph Springfeld & Karl Heinz Weiss. (2018) Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression. Gastrointestinal Tumors 5:1-2, pages 38-46.
Crossref
Sae Hwan Lee, Il Han Song, Ran Noh, Ha Yan Kang, Suk Bae Kim, Soon Young Ko, Eoum Seok Lee, Seok Hyun Kim, Byung Seok Lee, An Na Kim, Hee Bok Chae, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Jae Dong Lee & Heon Young Lee. (2015) Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions. BMC Cancer 15:1.
Crossref
A. Ruth He & Alec S. Goldenberg. (2013) Treating hepatocellular carcinoma progression following first-line sorafenib: therapeutic options and clinical observations. Therapeutic Advances in Gastroenterology 6:6, pages 447-458.
Crossref
Syamantak Majumder, Anne-Christine Piguet, Jean-François Dufour & Suvro Chatterjee. (2013) Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis. European Journal of Pharmacology 705:1-3, pages 86-95.
Crossref
Tamer Elbaz, Mohamed El Kassas & Gamal Esmat. (2013) Management of Hepatocellular Carcinoma: Updated Review. Journal of Cancer Therapy 04:02, pages 536-545.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.